Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a unified therapy tame both addiction and emotional disorders?

NCT ID NCT07738081

ENROLLING_BY_INVITATION Symptom relief Sponsor: University of Oviedo Source: ClinicalTrials.gov ↗

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This trial tests a 12-session cognitive-behavioral therapy designed to help people with substance use who also struggle with anxiety or depression. The therapy focuses on improving emotion regulation—the ability to understand and manage emotions—which may reduce addictive behaviors. Researchers will compare this approach to standard treatment in 60 participants receiving inpatient or outpatient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 12-session cognitive-behavioral therapy adapted from the Unified Protocol
What this could lead to
If it works, this could point toward a more effective psychological treatment for people struggling with both addiction and emotional disorders.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply broadly. The therapy requires 12 sessions, which may be difficult for some to complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADDICTIVE BEHAVIORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agoraphobia Behavior, Addictive Emotional Regulation generalized anxiety disorder major depressive disorder panic disorder social phobia substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADDICTIVE BEHAVIORS EMOTION REGULATION

Contacts and locations

Locations

  • University of Oviedo

    Oviedo, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.